Biopharm America 2011
BERLIN AND BOSTON, Sept. 6, 2011 /CNW/ - Germany has allocated over EUR
5.5 billion (nearly $8 billion) in federal grants to support healthcare
research over the next four years. The country trails only the US in
biopharmaceutical production, with this new program providing a boost
to bringing research results rapidly to market. Germany Trade & Invest will have biotechnology industry experts along with a business
delegation at this year's Biopharm America from September 7-9 in Boston
to share the latest business and partnering opportunities in Germany.
"Germany is already known as an established player in the pharmaceutical
industry. A wealth of innovative small and medium enterprises and
excellent opportunities for research partnerships are helping the
country maintain its edge," stated Gabriel Flemming, medical
biotechnology expert at Germany Trade & Invest in Berlin.
For years, the combination of policymaking, research and development,
venture capital and industry initiatives have taken Germany's industry
in a fresh direction. With an emphasis on biotechnology, the industry
is becoming increasingly sustainable while finding innovative ways to
tackle public health challenges.
"Germany is especially making progress in the field of personalized
medicine," continued Flemming. "Foreign companies and venture
capitalists are drawn to German biotechnology clusters, as diagnostics
firms are working closely with the biopharmaceutical industry to create
innovation hotbeds across the country."
Biotechnology regions can qualify for additional grants from the federal
government. BioM in Munich, for example, received millions for its work
in personalized medicine. Dr. Horst Domdey, Managing Director of BioM,
will join the Germany Trade & Invest delegation and inform companies of the partnering and investment
possibilities in this cluster.
Germany Trade & Invest is the foreign trade and inward investment promotion agency of the
Federal Republic of Germany. The organization advises foreign companies
looking to expand their business activities in the German market. It
provides information on foreign trade to German companies that seek to
enter foreign markets.
SOURCE Germany Trade and Invest
For further information:
Germany Trade & Invest